Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Clingan

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Cancer|July 23, 2003
Hepatic cryotherapy and regional chemotherapy with or without resection for liver metastases from colorectal carcinoma: how many are too many?Dong Bo Yan, Philip Clingan, David L Morris
Clinical Colorectal Cancer|June 5, 2018
Safety and Efficacy of Oxaliplatin Doublet Adjuvant Chemotherapy in Elderly Patients With Stage III Colon CancerDaniel Brungs, Morteza Aghmesheh, Paul de Souza, et al.
ANZ Journal of Surgery|April 22, 2006
Review of patients with peritoneal malignancy treated with peritonectomy and heated intraperitoneal chemotherapyReema Hadi, Vanessa Saunders, Olga Utkina, et al.
Exploration of Targeted Anti-Tumor Therapy|October 28, 2024
Evidence for the evolving role of neoadjuvant and perioperative immunotherapy in resectable non-small cell lung cancerThomas Hansen, Jonathon Hill, Gary Tincknell, et al.
The Oncologist|March 25, 2016
The Impact of Mismatch Repair Status in Colorectal Cancer on the Decision to Treat With Adjuvant Chemotherapy: An Australian Population-Based Multicenter StudyEmily Y He, Nicholas J Hawkins, Gabriel Mak, et al.
BMC Cancer|April 10, 2017
Sidedness is prognostic in locoregional colon cancer: an analysis of 9509 Australian patientsDaniel Brungs, Morteza Aghmesheh, Paul de Souza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2009
Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trialThierry André, Corrado Boni, Matilde Navarro, et al.
Asia-Pacific Journal of Clinical Oncology|June 23, 2018
nab-Paclitaxel plus gemcitabine in metastatic pancreatic adenocarcinoma: Australian subset analyses of the phase III MPACT trialRosemary Young, Paul Mainwaring, Philip Clingan, et al.
The New England Journal of Medicine|June 4, 2004
Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancerThierry André, Corrado Boni, Lamia Mounedji-Boudiaf, et al.
BMC Cancer|July 25, 2024
Pembrolizumab with platinum-based chemotherapy with or without epacadostat as first-line treatment for metastatic non-small cell lung cancer: a randomized, partially double-blind, placebo-controlled phase II studyMichael Boyer, Rina Hui, Damien Urban, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Cancer|July 23, 2003
Hepatic cryotherapy and regional chemotherapy with or without resection for liver metastases from colorectal carcinoma: how many are too many?Dong Bo Yan, Philip Clingan, David L Morris
Clinical Colorectal Cancer|June 5, 2018
Safety and Efficacy of Oxaliplatin Doublet Adjuvant Chemotherapy in Elderly Patients With Stage III Colon CancerDaniel Brungs, Morteza Aghmesheh, Paul de Souza, et al.
ANZ Journal of Surgery|April 22, 2006
Review of patients with peritoneal malignancy treated with peritonectomy and heated intraperitoneal chemotherapyReema Hadi, Vanessa Saunders, Olga Utkina, et al.
Exploration of Targeted Anti-Tumor Therapy|October 28, 2024
Evidence for the evolving role of neoadjuvant and perioperative immunotherapy in resectable non-small cell lung cancerThomas Hansen, Jonathon Hill, Gary Tincknell, et al.
The Oncologist|March 25, 2016
The Impact of Mismatch Repair Status in Colorectal Cancer on the Decision to Treat With Adjuvant Chemotherapy: An Australian Population-Based Multicenter StudyEmily Y He, Nicholas J Hawkins, Gabriel Mak, et al.
BMC Cancer|April 10, 2017
Sidedness is prognostic in locoregional colon cancer: an analysis of 9509 Australian patientsDaniel Brungs, Morteza Aghmesheh, Paul de Souza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2009
Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trialThierry André, Corrado Boni, Matilde Navarro, et al.
Asia-Pacific Journal of Clinical Oncology|June 23, 2018
nab-Paclitaxel plus gemcitabine in metastatic pancreatic adenocarcinoma: Australian subset analyses of the phase III MPACT trialRosemary Young, Paul Mainwaring, Philip Clingan, et al.
The New England Journal of Medicine|June 4, 2004
Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancerThierry André, Corrado Boni, Lamia Mounedji-Boudiaf, et al.
BMC Cancer|July 25, 2024
Pembrolizumab with platinum-based chemotherapy with or without epacadostat as first-line treatment for metastatic non-small cell lung cancer: a randomized, partially double-blind, placebo-controlled phase II studyMichael Boyer, Rina Hui, Damien Urban, et al.
Pageof 2